Long-term antibiotic treatment is required to cure tuberculosis. Targeted antibiotics should improve the efficacy of treatment by concentrating the drugs close to the bacteria. The aim of the present study was to synthesize targeted conjugates. For this purpose, we used mannose as a homing device to direct norfloxacin into macrophages. Dextran was used as the polymer bearing both mannose and norfloxacin. Using different peptide spacer arms to link norfloxacin to dextran, we demonstrated that norfloxacin acts as an antibiotic only when it is released in its native form. Also, targeting by using mannose as a homing device is required to achieve antimycobacterial activity in vivo. Thus, norfloxacin, which is inactive against mycobacteria in its native form in vivo, can be transformed into an active drug by targeting.

Synthesis, degradation and antimicrobial properties of targeted macromolecular prodrugs of norfloxacin / E. Roseeuw, V. Coessens, A.M. Balazuc, M. Lagranderie, P. Chavarot, A. Pessina, M.G. Neri, E. Schacht, G. Marchal, D. Domurado. - In: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. - ISSN 0066-4804. - 47:11(2003 Nov), pp. 3435-3441. [10.1128/AAC.47.11.3435-3441.2003]

Synthesis, degradation and antimicrobial properties of targeted macromolecular prodrugs of norfloxacin

A. Pessina;M.G. Neri;
2003

Abstract

Long-term antibiotic treatment is required to cure tuberculosis. Targeted antibiotics should improve the efficacy of treatment by concentrating the drugs close to the bacteria. The aim of the present study was to synthesize targeted conjugates. For this purpose, we used mannose as a homing device to direct norfloxacin into macrophages. Dextran was used as the polymer bearing both mannose and norfloxacin. Using different peptide spacer arms to link norfloxacin to dextran, we demonstrated that norfloxacin acts as an antibiotic only when it is released in its native form. Also, targeting by using mannose as a homing device is required to achieve antimycobacterial activity in vivo. Thus, norfloxacin, which is inactive against mycobacteria in its native form in vivo, can be transformed into an active drug by targeting.
Settore MED/07 - Microbiologia e Microbiologia Clinica
nov-2003
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/41371
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 34
social impact